MGMT and neoplasm: Besides these considerations, it is necessary to highlight that MGMT is not the only factor that can affect patients’ response to temozolomide; other mechanisms such as repairing DNA damage induced by chemotherapy [74,75], hindering the drug delivery [76], or acidifying the tumour microenvironments [12,13,77] are implemented by the tumour.